COX-2 inhibitors--first, do no harm.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 15778758)

Published in N Z Med J on March 11, 2005

Authors

Mark Weatherall, Sarah Aldington, Philippa Shirtcliffe, Brent Caldwell, Richard Beasley

Articles citing this

COX-2 inhibitors--second, do some good. N Z Med J (2005) 0.75

Articles by these authors

The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy (2004) 13.16

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2007) 4.67

Acetaminophen for Fever in Critically Ill Patients with Suspected Infection. N Engl J Med (2015) 3.57

Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet (2003) 3.52

Tiotropium Respimat increases the risk of mortality. Thorax (2013) 3.34

PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'. N Z Med J (2005) 2.54

A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol. Basic Res Cardiol (2012) 2.37

Community ambulation after stroke: how important and obtainable is it and what measures appear predictive? Arch Phys Med Rehabil (2004) 2.34

Limited generalisability of UPLIFT findings to clinical practice. Thorax (2013) 2.15

Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax (2011) 2.11

Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One (2010) 2.04

Buteyko pseudoscience. N Z Med J (2004) 2.02

British National Formulary for Children: the risk of inappropriate paracetamol prescribing. Arch Dis Child (2011) 1.88

Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Ann Allergy Asthma Immunol (2004) 1.84

Effects of cannabis on pulmonary structure, function and symptoms. Thorax (2007) 1.79

Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use. J Allergy Clin Immunol (2012) 1.78

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax (2006) 1.72

Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med (2006) 1.71

Relationship between process and outcome in stroke care. Stroke (2003) 1.70

Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respir Med (2013) 1.66

Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma. Respirology (2014) 1.64

How to write research papers and grants: 2011 Asian Pacific Society for Respirology Annual Scientific Meeting Postgraduate Session. Respirology (2012) 1.58

Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest (2005) 1.57

Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med (2007) 1.56

Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. Clin Ther (2004) 1.55

The New Zealand national junior doctors' strike: implications for the provision of acute hospital medical services. Clin Med (2008) 1.53

The all-age spirometry reference ranges reflect contemporary Australasian spirometry. Respirology (2011) 1.52

Complete reference ranges for pulmonary function tests from a single New Zealand population. N Z Med J (2006) 1.52

Tiotropium Respimat increases the risk of mortality: pro. Eur Respir J (2013) 1.51

Asthma exacerbations. 5: assessment and management of severe asthma in adults in hospital. Thorax (2007) 1.49

Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest (2005) 1.48

Do natural health food stores require regulation? N Z Med J (2002) 1.47

Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. N Z Med J (2005) 1.46

Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma. Respirology (2003) 1.46

Is it time to change the approach to oxygen therapy in the breathless patient? Thorax (2007) 1.45

A study of airline pilot morbidity. Aviat Space Environ Med (2012) 1.45

Smoking around hospitals. N Z Med J (2012) 1.40

High blood pressure advice given by natural health food stores. N Z Med J (2009) 1.38

External validity of randomized controlled trials in COPD. Respir Med (2006) 1.30

Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med (2012) 1.29

Questions asked and answered in pilot and feasibility randomized controlled trials. BMC Med Res Methodol (2011) 1.27

The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med (2010) 1.21

Is implicit sequence learning impaired in Parkinson's disease? A meta-analysis. Neuropsychology (2006) 1.19

Physiological associations of computerized tomography lung density: a factor analysis. Int J Chron Obstruct Pulmon Dis (2006) 1.18

Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med (2011) 1.17

The use of the self-management plan system of care in adult asthma. Prim Care Respir J (2004) 1.17

Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. N Z Med J (2009) 1.16

Prolonged work- and computer-related seated immobility and risk of venous thromboembolism. J R Soc Med (2010) 1.15

The Global Lung Initiative 2012 reference values reflect contemporary Australasian spirometry. Respirology (2012) 1.11

Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thromb Haemost (2007) 1.10

The association between SpO2 values and mortality--interpret with caution. Resuscitation (2012) 1.08

Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia? N Z Med J (2005) 1.07

How feasible is the attainment of community ambulation after stroke? A pilot randomized controlled trial to evaluate community-based physiotherapy in subacute stroke. Clin Rehabil (2008) 1.07

The effect of environment and task on gait parameters after stroke: A randomized comparison of measurement conditions. Arch Phys Med Rehabil (2006) 1.07

Seasonal variation in asthma-related hospital and intensive care unit admissions. J Asthma (2005) 1.05

The effect of hyperoxia following cardiac arrest - A systematic review and meta-analysis of animal trials. Resuscitation (2012) 1.05

Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J (2009) 1.04

The HEAT trial: a protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection. Crit Care Resusc (2012) 1.04

Is implicit sequence learning impaired in schizophrenia? A meta-analysis. Brain Cogn (2008) 1.02